Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

Sarama Completes Tranche 2 Options Placement

by admin February 11, 2025
February 11, 2025
Sarama Completes Tranche 2 Options Placement

Sarama Resources (SRR:AU) has announced Sarama Completes Tranche 2 Options Placement

Download the PDF here.

This post appeared first on investingnews.com

previous post
Crypto Market Recap: Saylor’s Strategy Resumes Bitcoin Buying
next post
When is the Starlink IPO Date and Can You Invest?

Related Posts

Saga Metals Expands Drilling at Radar Project, Unveiling...

March 12, 2025

Crypto Market Recap: Bitcoin Breaks US$100,000, Coinbase Makes...

May 11, 2025

Allied Critical Metals Closes First Tranche of Oversubscribed...

August 15, 2025

Brightstar Secures US$120M Bond to Fund Goldfields Project

March 4, 2026

Rick Rule: Where I See 10+ Bagger Potential,...

March 8, 2025

Nuvau Minerals Announces Amendment to Private Placement Terms

February 21, 2026

Heliostar Metals

November 28, 2025

Top 10 Graphite-producing Countries

February 12, 2025

Sankamap Updates Status on Late Filing of Financial...

November 5, 2025

Ted Butler: Silver’s Moment is Here, Time for...

July 15, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • Terms and Conditions
    • Privacy Policy

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved